gms | German Medical Science

27. Deutscher Krebskongress

Deutsche Krebsgesellschaft e. V.

22. - 26.03.2006, Berlin

Gastrointestinal Cancer including Liver

Meeting Abstract (OP165)

Combination of mTOR inhibitor and radiotherapy – a new strategy in multimodal therapy of malignant tumors

Manegold P, Paringer C, Kulka U, Wilkowski R, Jauch KW, Guba M, Bruns CJ
Meeting Abstract (OP166)

Incidence of gastrointestinal perforations (GI perf) and bleeding in patients starting bevacizumab treatment in first-line metastatic Colorectal cancer (mCRC) without primary tumour resection – Preliminary results from the First BEATrial

Kretzschmar A, Kettner E, Preiss J, Freier W, Trarbach T, Thuss-Patience P, Reichardt P, Van Cutsem E, Lutiger B, Cunningham D
Meeting Abstract (OP167)

Radiofrequency ablation for the treatment of liver tumors - Choice of the best approach

Schumacher G, Kunath A, Eisele R, Spinelli A, Neuhaus P
Meeting Abstract (OP168)

EGFR reactivates telomerase in immortalized squamous epithelial cells through PI3K/AKT-mediated phosphorylation and transcriptional regulation via Hif-1alpha

Heeg S, von Werder A, Doebele M, Quante M, Scheffer E, Goessel G, Fulda C, Kunert H, Nakagawa H, Beijersbergen R, Blum HE, Opitz OG
Meeting Abstract (OP169)

Combination Analysis of Activator Protein-1 Family Members, Sp1and an Activator Protein-2α-Related Factor Binding to Different Regions of the Urokinase Receptor (u-PAR) Gene in Resected Colorectal Cancers

Schewe D, Biller T, Maurer G, Assangani I, Leupold J, Lengyel E, Post S, Allgayer H
Meeting Abstract (OP170)

Loss of the „Coxsackie und Adenovirus Receptor (CAR)“ expression correlates with poor clinical outcome, tumor dedifferentiation, increased proliferation, and occurrence of distant metastasis in gastric adenocarcinomas

Anders M, Vieth M, Koschel A, Wiedenmann B, Röcken C, Ebert M, Kemmner W, Höcker M
Meeting Abstract (OP171)

Role of Src-family kinases in Gastrointestinal Stromal Tumors

Bauer S, Demetri GD, Fletcher JA
Meeting Abstract (OP172)

Development of the novel Double Enriched Nested PCR (DEN-PCR) assay for detection of K-ras Codon 12 mutations in colorectal carcinoma patients

Kraus MC, Berger MR
Meeting Abstract (OP173)

Final report of assessment of response to neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma patients by 18-FDG-PET

Brücher B, Wieder H, Becker K, Weiss W, Busch R, Lordick F, Stein H, Zimmermann F, Molls M, Fink U, Schwaiger M, Siewert JR
Meeting Abstract (OP174)

Preliminary safety of bevacizumab with first-line FOLFOX, CAPOX, FOLFIRI and Capecitabine for mCRC - First BEATrial

Kretzschmar A, Preiss J, Kettner E, Trarbach T, Richter S, Pink D, Cunningham D, Lutiger B, Van Cutsem E
Meeting Abstract (OP175)

Moderate-dose Radio-Chemotherapy plus Resection versus High-dose Radio-Chemotherapy alone for Locally Advanced Esophageal Cancer considering a New Prognostic Factor

Rades D, Schneider T, Yekebas EF, Muellerleile U, Gross E, Izbicki JR, Alberti W
Meeting Abstract (OP176)

Small bowel adenocarcinoma: cytotoxic chemotherapy for metastatic disease seemes to be more effective than commonly thought - Retrospective analysis of 39 cases

Kretzschmar A, Hofheinz RD, Stahl M, Thuss-Patience PC, Pink D, Burkart C, Mrozek A, Klima K, Reichardt P, Hartmann JT
Meeting Abstract (OP177)

Phase II Trial of Repeated Carcinoembryonic Antigen (CEA) Radioimmunotherapy (RAIT) with 131I-Labetuzumab Post Salvage Resection of Colorectal Liver Metastases

Liersch T, Meller J, Lorf T, Sahlmann CO, Langer C, Ghadimi BM, Wegener WA, Becker H, Goldenberg DM
Meeting Abstract (PO178)

Lokalrezidiv bei Rektumkarzinomen: Stellenwert der 18F-FDG PET/CT-Diagnostik

Blumstein N, Blumstein C, Messer P, Schmid I, Conzelmann A, Röttinger E, Reske SN
Meeting Abstract (PO179)

Weekly high-dose 5-FU as 24h-infusion and folinic acid (AIO regimen) plus Irinotecan in patients with advanced non-resectable adenocarcinoma or squamous epithelial carcinoma of the oesophagus: interim analysis of a phase II trial

Boxberger F, Wolff K, Brueckl V, Brueckl W, Meier C, Maennlein G, Horbach T, Hohenberger W, Hahn EG, Wein A
Meeting Abstract (PO180)

Influence of the department on the resection rate in palliative treatment of metastatic colorectal cancer (CRC)

Wein A, Liersch T, Hofheinz R, Fahlke J, Wilke J, Brueckl WM, Maennlein G, Kohnen R, Boxberger F, Hahn EG, Hohenberger W
Meeting Abstract (PO181)

Effect of probiotics and triple eradication therapy on the cyclooxygenase (COX)-2 expression, apoptosis and functional gastric impairment in the animal model of Helicobacter pylori-induced carcinogenesis

Konturek PC, Brzozowski T, Konturek S, Stachura J, Hahn EG
Meeting Abstract (PO182)

Surgical therapy of hepatocellular carcinoma

Yedibela S, Zhang W, Meyer T, Hohenberger W
Meeting Abstract (PO183)

Does a negative screening colonoscopy ever need to be repeated?

Brenner H, Chang-Claude J, Seiler CM, Stürmer T, Hoffmeister M
Meeting Abstract (PO184)

Factors influencing the prognosis of incidental gallbladder carcinoma

Götze T, Paolucci V
Meeting Abstract (PO185)

Diagnostic Value of Bile Duct Brushings Cytology in the Surveillance of Patients with Primary Sclerosing Cholangitis: A Clinical Study of 120 Patients

Al-Abadi H, Abou-Rebyeh H, Veltzke-Schliecker W, Neuhaus R, Berg T, Al-Khalili Z, Jonas S, Rösch T, Dürr A, Neuhaus P
Meeting Abstract (PO186)

Can Gemcitabine Improve the Treatment Results of Radiochemotherapy in Pancreatic Cancer? Results of Two Consecutive Monoinstutional Studies

Micke O, Schäfer U, Schüller P, Bruns F, DeVries A, Willich N
Meeting Abstract (PO187)

Use of Cell Image Analysis in the Detection of Cancer from Specimens obtained duringERC in PSC patients for screening in order to schedule patients at high risk for liver transplantation

Schmeding M, Schmeding M, Al-Abadi H, Abou-Rebyeh H, Veltzke-Schlieker W, Al-Kahlili Z, Dürr A, Neuhaus R, Berg T, Jonas S, Rösch T, Neuhaus P
Meeting Abstract (PO188)

Incidence of bladder outlet obstruction after rectal surgery

Zugor V, Miskovic I, Matzel K, Hohenberger W, Schott G
Meeting Abstract (PO189)

Identification of the gene coding for the Serine Proteinase Inhibitor kazal-type 1 (SPINK1) as the most uniform overexpressed gene in HCV-induced Hepatocarcinogenesis by genomic profiling using Oligonucleotide-MicroArrays

Hass HG, Jobst J, Nehls O, Hartmann JT, Kaiser S
Meeting Abstract (PO190)

HIF-1α inhibition impairs normoxic epithelial-mesenchymal transition in gastric cancer cells

Rohwer N, Vieth M, Kemmner W, Schlag PM, Cramer T, Höcker M
Meeting Abstract (PO191)

Epoetin alfa Improves Survival and Local Control after Chemoradiation for Stage III Esophageal Cancer: Final Results of a Prospective Study

Rades D, Tribius S, Yekebas EF, Muellerleile U, Gross E, Schild SE, Izbicki JR, Alberti W
Meeting Abstract (PO192)

Incidence of erectile dysfunctions after rectal operations

Zugor V, Miskovic I, Matzel K, Hohenberger W, Schott G
Meeting Abstract (PO193)

Prognostic significance of local macroscopic and microscopic tumor factors at multimodality treated pancreatic patients

Wilkowski R, Bruns C, Diebold J, Heinemann V
Meeting Abstract (PO194)

Safety of anemia-therapy with erythropoietin-alfa during neoadjuvant platin-based chemotherapy for locally advanced esophagogastric adenocarcinoma.

Abbrederis K, Bassermann F, Schuhmacher C, Voelter V, Busch R, Röthling N, Siewert JR, Peschel C, Lordick F
Meeting Abstract (PO195)

Inhibition of Barrett's adenocarcinoma cell growth by simvastatin: involvement of COX-2 and apoptosis-related proteins

Konturek PC, Burnat G, Hahn EG, Raithel M
Meeting Abstract (PO196)

Risk reduction of colorectal cancer with long-term use of low-dose aspirin and nonsteroidal anti-inflammatory drugs

Hoffmeister M, Chang-Claude J, Brenner H
Meeting Abstract (PO197)

Results of secondary resection after responding to chemotherapy and reaching operability after primarily inoperable gastric cancer

Fahlke J, Schmidt C, Stübs P, Hribaschek A, Schmidt S, Zierau K, Schulz HU, Lippert H
Meeting Abstract (PO198)

Combination of mTOR inhibitor and radiotherapy – a new strategy in multimodal therapy of malignant tumors

Manegold P, Paringer C, Kulka U, Wilkowski R, Jauch KW, Guba M, Bruns CJ
Meeting Abstract (PO199)

Expression of cathepsin B in gastric adenocarcinomas represents a prognostic marker

Baldus SE, Mönig SP, Nolte S, Grass G, Bollschweiler E, Hölscher AH, Dienes HP
Meeting Abstract (PO200)

Metastatic Gastroenteropancreatic Neuroendocrine Tumors: The Revised WHO Classification and its Correlation with Somatostatin Analog Uptake

Ezziddin S, Yong-Hing C, Ahmadzadehfar H, Fischer HP, Habibi E, Leifeld L, Biersack HJ
Meeting Abstract (PO201)

Helicobacter pylori controls serine and tyrosine phosphorylation of cortactin to induce actin cytoskeletal rearrangements and host cell scattering

Wittelsberger R, Meyer F, Brandt S, Tegtmeyer N, König W, Backert S
Meeting Abstract (PO202)

Prediction of response to chemotherapy using 18-fluorodeoxyglucose positron emission tomography in advanced oesophageal and gastric cancer

Lorenzen S, Herrmann K, Wieder H, Hennig M, Bredenkamp R, Peschel C, Schwaiger M, Lordick F
Meeting Abstract (PO203)

Ki-67 Auto-Antibodies of Colorectal Cancer Patients

Duchrow M, Ziems C, Broll R, Habermann JK, Roblick UJ, Bruch HP
Meeting Abstract (PO204)

Significance of acetone treatment for lymph node preparation and staging in colorectal specimens

Richter D, Lorenz D, Fisseler-Eckhoff A
Meeting Abstract (PO205)

Preoperative hospital information program for cancer patients in surgery and their relatives: First results

Berend M, Teren K, Küchler T, Kremer B
Meeting Abstract (PO206)

Hox- and MMP- gene family members are expressed in freshly frozen and paraffin embedded metastatic colorectal carcinoma – implication for response prediction to a palliative 5-FU containing chemotherapy

Brueckl WM, Wirtz R, Croner RS, Boxberger F, Gentner B, Schuppert A, Meyer T, Papadopoulos T, Hahn EG, Hohenberger W, Wein A
Meeting Abstract (PO207)

PD-1/PD-L1 expression in colorectal cancer and its implications for apoptosis and tumor immune evasion

Gasser M, Grimm M, Nichiporuk E, Bueter M, Lebedeva T, Lutz J, Koenigshausen M, Thalheimer A, Thiede A, Heemann U, Meyer D, Waaga-Gasser AM
Meeting Abstract (PO208)

Combination of radiofrequency (RF) ablation and systemic chemotherapy for colorectal liver metastases: A prospective phase II study

Burkart C, Hartmann JT, Bitzer M, Käfer G, Clasen S, Kanz L, Pereira P
Meeting Abstract (PO209)

Improvements of prognosis of gastrointestinal tumours: results of the Munich Cancer Registry

Engel J, Hölscher G, Eckel R, Schubert-Fritschle G, Hölzel D
Meeting Abstract (PO210)

Socio-economic status and gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST)

Nagel G, Linseisen J, Del Giudice G, González CA, Riboli E
Meeting Abstract (PO211)

Bolus MIT Tomycin C in Combination with Protracted Infusional 5-Flurouracil/Folinic Acid in Pretreated Patients with Advanced Gastric Adenocarcinoma: Results of an Extended Phase II Study

Hartmann JT, Quietzsch D, Al-Batran SE, Pintoffl J, Nehls O, Käfer G, Burkart C, Kanz L
Meeting Abstract (PO212)

Inhibition of telomerase by mutant template telomerase RNA and anti-telomerase short interfering RNA induces ALT in immortalized human esophageal epithelial cells.

Döbele M, von Werder A, Fulda C, Heeg S, Gössel G, Quante M, Harada H, Suliman Y, Li S, Blackburn EH, Blum HE, Opitz OG
Meeting Abstract (PO213)

CONKO-101: Erste Ergebnisse einer offenen Phase II Studie mit Gemcitabin, 5-FU (24h), Folinsäure und Cisplatin bei Patienten mit inoperablem Ösophaguskarzinom

Stieler J, Hilbig A, Pelzer U, Roll L, Dörken B, Riess H, Oettle H
Meeting Abstract (PO214)

Peculiarities of Gastric Carcinomas in Patients under 50 Years of Age

Schildberg C, Merkel S, Dimmler A, Horbach T, Hohenberger W
Meeting Abstract (PO215)

Surgical endoscopy compared to non-surgical endoscopy in patients with esophageal cancer. Is it any better?

Colombo-Benkmann M, Vowinkel T, Palmes D, Tübergen D, Brüwer M, Senninger N
Meeting Abstract (PO216)

Bile salts induce COX-2 expression in Barrett adenocarcinoma cells via stimulation of NFkappaB

Konturek PC, Burnat G, Hahn EG
Meeting Abstract (PO217)

Significance of the anti-inflammatory factor hemeoxgenase-1 (HO-1) for the function of tumour infiltrating macrophages

Benckert C, Rohwer N, Cramer T, Spinelli A, Neuhaus P, Jonas S
Meeting Abstract (PE218)

Chemotherapy-induced long-term complete remission of the primary in patients with stage IV colorectal cancer. Report of three consecutive cases

Güldenzoph B, Armbrust T, Ramadori G
Meeting Abstract (PE219)

Transanal endoscopic microsurgery (TEM) and radiochemotherapy (RCT) in early rectal cancer

Zimmermann F, Riedl W, Molls M, Bues G
Meeting Abstract (PE220)

Association of CPT-11 pharmacokinetics and non-hematological toxicity in patients with advanced gastrointestinal cancer and influence of age

Merkel U, Farker K, Rückert M, Wedding U, Hippius M, Höffken K, Hoffmann A
Meeting Abstract (PE221)

New stool tests for colorectal cancer screening: a systematic review focusing on performance characteristics and practicalness

Haug U, Brenner H
Meeting Abstract (PE222)

Chemokine receptors CXCR4 and CCR7 influence proliferation and dissemination of human hepatocellular cancer

Schimanski CC, Bahre R, Teufel A, Simiantonaki N, Wilsberg V, Wehler T, Achenbach T, Galle PR, Moehler M
Meeting Abstract (PE223)

Outcome of patients with colorectal cancer and synchronous metastases (UICC IV)

Gog C, Pession U, Sachs M, Bechstein WO
Meeting Abstract (PE224)

Lymphatic vessel density in pancreatic carcinoma

Assmann G, KLEESPIES A, Nolte A, Wilkowski R, Bruns C, Diebold J
Meeting Abstract (PE225)

Small cell cancer of the anal canal – Report of a rare case

Meyer A, Bruns F, Richter K, Grünwald V, Karstens JH
Meeting Abstract (PE226)

Health economic evaluation of a newly developed oxaliplatin solution in comparison to the conventional lyophilisate

Sievert M, Deuß B, Frick M, Rosenfeld S
Meeting Abstract (PE227)

The Rap1/B-Raf signaling complex is a putative therapeutic target in neuroendocrine tumors of the digestive tract

Schrader J, Hörsch D, Arnold R
Meeting Abstract (PE228)

5-FU/FA/Mitomycin as second to fourth-line chemotherapy in patients with advanced colorectal cancer: A retrospective analysis

Güse-Gocht K, Klose G, Ramsauer B, van de Loo I, Spehn J
Meeting Abstract (PE229)

Single-nucleotide polymorphism (SNP) of ABCB1 transporter in colorectal cancer patients and relation to the pharmacokinetics of irinotecan

Farker K, Merkel U, Wedding U, Hippius M, Höffken K, Hoffmann A
Meeting Abstract (PE230)

Proteasominhibitoren sensitivieren HCC Zellinien aber nicht primäre humane Hepatozyten für TRAIL-induzierte Apoptose durch verstärkte Caspase-8 Rekrutierung am DISC unabhängig von NF-kB

Ganten T, Ganten TM, Koschny R, Sykora J, Haas T, Fas S, Stremmel W, Walzcak H
Meeting Abstract (PE231)

Docetaxel as salvage therapy in highly pretreated and chemo-resistant gastrointestinal tumors

Sprinzl M, Schleef S, Dahmen A, Galle P, Kanzler S, Moehler M
Meeting Abstract (PE232)

Metastatic Colon Cancer in pregnancy: a treatment concept

Himsl I, Lenhard M, von Koch F, Wichmann M, Schulze A, Hasbargen U, Friese K
Meeting Abstract (PE233)

Prospective evaluation of novel tests for early detection of colorectal cancer (BLITZ-Study)

Haug U, Koßmehl S, Sieg A, Brenner H
Meeting Abstract (PE234)

First line therapy of metastatic colon cancer with 5-FU, folinic acid and bevacizumab in chronic renal failure: Complete remission in a patient with advanced colon cancer undergoing hemodialysis

Jochims C, Ring A, Stremmel W, Jäger D, Herrmann T
Meeting Abstract (PE235)

Irinotecan/Capecitabine versus Cisplatin/Capecitabine in Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction: Preliminary Results of a Randomized German AIO Phase II-Study

Möhler M, Geissler M, Kanzler H, Raedle J, Malfertheiner P, Fischbach W, Scheruebl H, Seufferlein T, Galle PR, Hoehler T
Meeting Abstract (PE236)

Cholangiocellular carcinoma responding on Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) – A Case Report

Sprinzl M, Schimanski C, Galle P, Moehler M, Kanzler S
Meeting Abstract (PE237)

Case reports: Treatment of progressive, metastatic, non functioning neuroendocrine tumours (NET) with Octreotide

Gog C, Pession U, Wullstein C, Bechstein WO
Meeting Abstract (PE238)

Comparative analysis of prognostic factors of Adeno (AC)- and squamous cell cancer (SCC) of the esophagus

Colombo-Benkmann M, Meyer B, Brüwer M, Senninger N